Influenza Vaccine Attitudes, Intent, and Receipt: Pediatric

Overview

Influenza vaccine is recommended as routine care for all individuals who are at least 6 months of age and older. Recently, questions about vaccine safety and concerns for side effects have increased, contributing to both influenza vaccine hesitancy and refusal. In an effort to educate parents and patients, public health entities and physicians give informational handouts in various forms. However, recent publications have found that pro-vaccine messages can have paradoxical effects on vaccine intentions, therefore further studies on vaccine related public health communication is needed. Few, if any, studies have analyzed the relationship between influenza vaccine attitudes and intention with actual vaccine receipt in the pediatric population. These results will help to understand the relationship between parent's vaccine perception and the intent to vaccinate versus the child's receipt of the influenza vaccine, as well as to optimize educational information given to families regarding the influenza vaccine.

Full Title of Study: “Influenza Vaccine Attitudes, Intent, and Receipt”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Health Services Research
    • Masking: Single (Outcomes Assessor)
  • Study Primary Completion Date: May 31, 2017

Interventions

  • Behavioral: Local educational information
    • Participants in this arm receive educational information regarding influenza vaccination based on local educational information.
  • Behavioral: National educational information
    • Participants in this arm receive educational information regarding influenza vaccination based on national educational information.

Arms, Groups and Cohorts

  • Experimental: Local educational data
    • Local-based educational handout
  • Experimental: National educational data
    • National-based educational handout
  • No Intervention: Usual care
    • No educational information other than provided as usual care by health care providers

Clinical Trial Outcome Measures

Primary Measures

  • Number of children who receive influenza vaccination on day of intervention
    • Time Frame: Day 0
    • Receipt of influenza vaccination by the child on the day of the educational intervention

Secondary Measures

  • Number of children who receive influenza vaccination during the influenza vaccine season
    • Time Frame: Up to 7 months
    • Receipt of influenza vaccination by the child by April 2017
  • Number of parents who anticipate influenza vaccination during the influenza vaccine season
    • Time Frame: Up to 7 months
    • Parents report planned receipt of influenza vaccination by themselves by April 2017

Participating in This Clinical Trial

Inclusion Criteria

  • Age at least 6 months

Exclusion Criteria

  • Receipt of influenza vaccination that season

Gender Eligibility: All

Minimum Age: 6 Months

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Columbia University
  • Provider of Information About this Clinical Study
    • Principal Investigator: Melissa Stockwell, Associate Professor of Pediatrics and Population and Family Health – Columbia University
  • Overall Official(s)
    • Melissa Stockwell, MD MPH, Principal Investigator, Columbia University

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.